1998
DOI: 10.1093/protein/11.4.285
|View full text |Cite
|
Sign up to set email alerts
|

A SequenceSpace analysis of Lys49 phopholipases A2: clues towards identification of residues involved in a novel mechanism of membrane damage and in myotoxicity

Abstract: 'SequenceSpace' analysis is a novel approach which has been used to identify unique amino acids within a sub-family of phospholipases A2 (PLA2) in which the highly conserved active site residue Asp49 is substituted by Lys (Lys49-PLA2s). Although Lys49-PLA2s do not bind the catalytic co-factor Ca2+ and possess extremely low catalytic activity, they demonstrate a Ca2+-independent membrane damaging activity through a poorly understood mechanism, which does not involve lipid hydrolysis. Additionally, Lys49-PLA2s p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(34 citation statements)
references
References 1 publication
0
34
0
Order By: Relevance
“…Amino acid substitutions in the active site or Ca 21 -binding loop have been also reported in Group I and II PLA2s (Valentin and Lambeau, 2000). Among them, several catalytically inactive PLA2s from snake, where the critical Asp49 residue is substituted with Lys, Ser, or Arg, have been demonstrated to retain Ca 21 -independent pharmacological and antibacterial activities (Murakami et al, 2007;Paramo et al, 1998;Petan et al, 2007;Ward et al, 1998). These studies reveal that biological activities of venom PLA2s are not simply correlated with their catalytic properties, suggesting that the PLA2 of O. drewseni could have the Ca 21 -independent venomous activity regardless of its lack of catalytic activity.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Amino acid substitutions in the active site or Ca 21 -binding loop have been also reported in Group I and II PLA2s (Valentin and Lambeau, 2000). Among them, several catalytically inactive PLA2s from snake, where the critical Asp49 residue is substituted with Lys, Ser, or Arg, have been demonstrated to retain Ca 21 -independent pharmacological and antibacterial activities (Murakami et al, 2007;Paramo et al, 1998;Petan et al, 2007;Ward et al, 1998). These studies reveal that biological activities of venom PLA2s are not simply correlated with their catalytic properties, suggesting that the PLA2 of O. drewseni could have the Ca 21 -independent venomous activity regardless of its lack of catalytic activity.…”
Section: Discussionmentioning
confidence: 98%
“…The basic function of PLA2 is the hydrolysis of phospholipids to lysophospholipids and free fatty acids using Ca 21 as a co-factor (Six and Dennis, 2000). In addition, some catalytic venom PLA2s are known to have other physiological functions, including presynaptic and postsynaptic neurotoxicity (Bon et al, 1979), myotoxicity (Krizaj et al, 1991;Mebs and Samejima, 1986;Ward et al, 1998), hemolytic activity (Costa and Palma, 2000;de Oliveira and Palma, 1998;Ho and Ko, 1988), anticoagulant activity (Andriao-Escarso et al, 2002;Jabeen et al, 2005), and antibacterial activity (Nevalainen et al, 2008). Secretory PLA2s typically have 5-8 intramolecular disulfide bridges and a highly conserved active site and Ca 21 -binding loop (Scott et al, 1990a,b;Verheij et al, 1980;White et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…The PLA 2 family is classified into two forms; cytosolic isoforms and secretary isoforms, involved in signal transduction pathway and inflammation pathway [8]. The catalytic mechanism of PLA 2 is common throughout the family with the conserved three-dimensional structure, but only at the sequence level, differences can be observed [9,10]. PLA 2 exists as monomer, dimer and trimeric form depending on the source [11].…”
Section: Inflammationmentioning
confidence: 99%
“…A number of models have been proposed to account for the molecular basis of their pharmacological activities; however the structural determinants remain elusive [10,11,[14][15][16][17][18][19][20][21]. Lys49-PLA 2 homologues have also been implicated in the inhibition of the vascular endothelial growth factor [22] and exhibit broad antibacterial activities [23,24], indicating their clinical and biomedical relevance.…”
Section: Introductionmentioning
confidence: 99%